Hylauronic Acid
PreclinicalSmall molecule
Hylauronic Acid is one of 3 small molecule programs targeting Hyaluronic Acid. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
3 competitors in Hyaluronic Acid
#DrugCompanyPhaseTrials
1Activella
Eli LillyPreclinical
Hylauronic Acid
UUniversity of Seville
Preclinical
Hyaluronan
HHadassah Medical Organization
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Hylauronic Acid. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Seville